[1]
2023. ATHEROGENIC INDICATIONS IN THYROIDISIM PATIENTES AND THE RISK OF CARDIOVASCULAR DISEASES: ATHEROGENIC INDICATIONS IN THYROIDISIM PATIENTES AND THE RISK OF CARDIOVASCULAR DISEASES. Iraqi Journal of Market Research and Consumer Protection. 15, 2 (Dec. 2023), 74–82. DOI:https://doi.org/10.28936/10.28936/(1)jmracpc11.2.2019.